Viewing Study NCT06308159


Ignite Creation Date: 2025-12-24 @ 2:41 PM
Ignite Modification Date: 2026-01-05 @ 8:28 AM
Study NCT ID: NCT06308159
Status: RECRUITING
Last Update Posted: 2025-11-25
First Post: 2024-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia
Sponsor: Lantu Biopharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module